Abstract

Inflammation of vasculature involving small to medium vessels associated with antineutrophil cytoplasmic antibodies or ANCA are collectively referred to as ANCA vasculitidis. In majority of such disorders there are few or no immune deposits and hence the term- “pauci immune vasculitis”. The three main conditions included in this group include microscopic polyangiitis, Granulomatosis with polyangiitis (GPA) - formerly known as Wegener’s granulomatosis, and Eosinophilic Granulomatosis with Polyangiitis (EGPA)-formerly known as Churg-Strauss Syndrome. There have been several advances in the last two decades in the classification, understanding of the pathogenesis and management of these conditions. To provide an update on the classification, pathology and pathogenesis and therapeutic advances for management of ANCA vasculitis is the focus of this in depth review.

Highlights

  • ANCA Associated Vasculitides (AAV) comprises a group of multi-systemic diseases affecting small-to-medium-sized vessels and is characterized by the presence of Anti-Neutrophil Cytoplasmic Antibodies (ANCA) with specificity for either Proteinase-3 (PR3) or Myeloperoxidase (MPO)

  • We developed a more clear understanding of how ANCA exert their effects to cause disease

  • AAV is characterized by pauci-immunity and absence of immune complexes; compelling evidences suggest the role of complement

Read more

Summary

Introduction

ANCA Associated Vasculitides (AAV) comprises a group of multi-systemic diseases affecting small-to-medium-sized vessels and is characterized by the presence of Anti-Neutrophil Cytoplasmic Antibodies (ANCA) with specificity for either Proteinase-3 (PR3) or Myeloperoxidase (MPO). The kidneys are vascular organs and are targets for different types of systemic vasculitides, in particular those affecting small vessels. The primary renal sites for small-vessel vasculitides are the glomeruli the most common clinical presentations are those of glomerulonephritis. The characteristic kidney lesions in these conditions are pauci-immune focal and segmental necrotizing and crescentic glomerulonephritis (NCGN). Active pauci-immune small vessel vasculitis is typically associated with circulating ANCA antibodies (ANCA vasculitis). NCGN may occur without extra renal manifestations of disease. ANCA-associated-vasculitis (AAV) comprises three different diseases entities: 1- Eosinophilic Granulamatosis with Polyangiitis (EGPA) formerly known as Churg-Strauss Syndrome (CSS). 3- Granulomatosis with Polyangiitis (GPA) previously known as Wagener’s Granulomatosis (WG)

Nomenclature and classification of vasculitis
Role of ANCAs
The role of the complement system
The role of T cells
Other Factors
Environmental factors
Clinical Presentations and Diagnosis
Renal manifestations
Other manifestations
As sess ment of Dise ase Severi ty
Diagnostic Evaluations
Radiographic tests
Detection of ANCA
Generalized Severe
Induction therapy
versus oral cyclophosphamide
Pulses
Use in intolerance to CYC and in young patients
In patients with moderate renal involvement who cannot take cyclophosphamide
Mycophenolate mofetil
Rituximab IV
Treatment of refractory and relapsing disease
Intravenous immunoglobulin
Allogeneic hematopoietic stem cell transplantation
Treatment of relapses
Findings
Potential novel therapies
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call